Marimed (MRMD) Change in Receivables (2014 - 2026)

Marimed (MRMD) has 13 years of Change in Receivables data on file, last reported at $401000.0 in Q1 2026.

• On a quarterly basis, Change in Receivables rose 32.34% year-over-year to $401000.0 in Q1 2026; TTM through Mar 2026 was $527000.0, a 76.23% decrease from a year earlier, with the FY2025 full-year figure at $429000.0, down 64.46% from the prior year.
• Change in Receivables for Q1 2026 stood at $401000.0, down from $1.4 million in the prior quarter.
• Over the last five years, Change in Receivables for MRMD reached as high as $2.0 million in Q4 2022 and fell as low as -$1.6 million in Q2 2025.
• Historically, Change in Receivables has averaged $711705.9 across 5 years, with a median of $1.1 million in 2023.
• Across the five-year window, Change in Receivables tumbled 635.61% in 2024 and jumped 160.85% in 2025, its largest moves.
• Year by year, Change in Receivables stood at $2.0 million in 2022, then tumbled by 46.48% to $1.1 million in 2023, then increased by 11.05% to $1.2 million in 2024, then increased by 15.3% to $1.4 million in 2025, then sank by 71.4% to $401000.0 in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $401000.0 in Q1 2026, $1.4 million in Q4 2025, and $328000.0 in Q3 2025.